VA GERD Claims: DC 7206 Ratings and Service Connection

What the VA Counts as Gastroesophageal reflux disease (GERD)

GERD is a chronic condition in which stomach acid repeatedly flows back up into the esophagus, the tube that connects the throat to the stomach. The common symptoms are heartburn, regurgitation, chest discomfort, and difficulty or pain when swallowing (called dysphagia). Over time, repeated acid exposure can inflame or narrow the esophagus. That narrowing is called an esophageal stricture, and as you will see below, the current VA rating turns heavily on whether a stricture is documented.

For VA purposes, GERD is now rated under 38 CFR 4.114, diagnostic code 7206, which is specifically titled "Gastroesophageal reflux disease." That code does not stop at GERD. Note 3 to DC 7206 states that it applies to a broad family of esophageal conditions, including esophagitis (mechanical or chemical), Mallory Weiss syndrome from caustic ingestion, drug-induced or infectious esophagitis, idiopathic eosinophilic or lymphocytic esophagitis, esophagitis from radiation therapy, esophagitis due to peptic stricture, and any esophageal condition that requires treatment with sclerotherapy.

The 2024 Code Transition: From DC 7346 to DC 7206

This is the single most important thing to understand about a GERD claim today, because most older guides on the internet are now out of date.

What changed, in plain language

• Before the 2024 reorganization: GERD was not its own code. Raters evaluated it by analogy, most often under DC 7346 (hiatal hernia), which topped out at 60 percent for symptoms such as persistent pyrosis (heartburn), regurgitation, substernal or arm or shoulder pain, and dysphagia productive of considerable impairment of health.
• After the 2024 reorganization: GERD is DC 7206. The ladder is 0/10/30/50/80, and the criteria are built around documented esophageal stricture, dysphagia, the number of dilatation procedures per year, stent or PEG tube placement, aspiration, and substantial weight loss. The highest available schedular rating is 80 percent.

When a regulation changes, the VA generally applies the version of the rule that is more favorable to the veteran for the period each version was in effect. The VA's own manual guidance and longstanding case law direct raters to consider both the old and new criteria for a claim that was pending across the change, and to use whichever yields the higher evaluation for the relevant time period. In practice this means a claim filed before the May 2024 effective date may still be evaluated under the old DC 7346 criteria for the earlier period, while a claim filed after that date is evaluated under DC 7206. This guide reports what the regulation says. It does not predict which version applies to any individual file.

DC 7206 Rating Levels

The full current title in the schedule is "Gastroesophageal reflux disease." Both GERD and the closely related esophageal stricture code (DC 7203) use the same five-step ladder. The rating is driven by documented structural findings and treatment, not by symptom severity alone. Here are the criteria, taken verbatim from 38 CFR 4.114.

80 percent is the maximum schedular rating for GERD. There is no 60 percent and no 100 percent level under DC 7206. The plain-language version of each row is below.

The other notes from the regulation:

• Note 1: Findings must be documented by barium swallow, computerized tomography, or esophagogastroduodenoscopy.
• Note 2: Non-gastrointestinal complications of procedures should be rated under the appropriate system.
• Note 3: This code applies to a broad list of esophageal conditions, including esophagitis (mechanical or chemical), Mallory Weiss syndrome from caustic ingestion, drug-induced or infectious esophagitis, idiopathic eosinophilic or lymphocytic esophagitis, esophagitis from radiation therapy, esophagitis due to peptic stricture, and any esophageal condition that requires treatment with sclerotherapy.
• Note 4: "Recurrent" esophageal stricture means the inability to maintain target esophageal diameter beyond 4 weeks after the target diameter has been achieved.
• Note 5: "Refractory" esophageal stricture means the inability to achieve target esophageal diameter despite receiving no fewer than 5 dilatation sessions performed at 2-week intervals.

The "substantial weight loss" used in the 80 percent row is defined at 38 CFR 4.112(a) as an involuntary loss greater than 20 percent of baseline weight, sustained for three months, with diminished quality of self-care or work tasks.

How Gastroesophageal reflux disease (GERD) Gets Service Connected

Direct service connection

Direct service connection requires the three standard elements: a current GERD diagnosis, an in-service event or onset (for example, documented reflux, dyspepsia, or treatment during service), and a medical nexus linking the two. The framework a direct claim is decided under is described in M21-1, Part V, Subpart i, Chapter 1, Section A. In the Board's published decisions, the missing nexus is by far the most common reason a direct GERD service-connection claim is denied. Of 3,562 classified service-connection denials for GERD, 2,326 were for lack of a nexus, 704 for no in-service event, and 532 for no current diagnosis (published BVA decisions, denial-reason dataset).

Presumptive service connection

There is no toxic-exposure presumptive for GERD itself. GERD is a structural and functional reflux condition with a known cause, so it is not on any Agent Orange, burn pit, or PACT Act presumptive list, and it is not one of the eight Camp Lejeune presumptive conditions. One narrow, adjacent pathway exists for Persian Gulf War veterans: the VA presumes service connection for qualifying chronic, medically unexplained "functional gastrointestinal disorders," a group the VA defines to include irritable bowel syndrome, functional dyspepsia, and functional abdominal pain syndrome, that are at least 10 percent disabling. The current presumptive window runs through December 31, 2026. That pathway covers functional GI disorders without structural change, not a diagnosed structural GERD or esophageal stricture, so it is adjacent rather than a GERD presumptive. See the VA's Gulf War medically unexplained illness page and the presumptive-period extension notice.

Secondary to a service-connected mental-health condition (medication side effects)

This is one of the strongest and most common winning theories for GERD. Many medications used to treat service-connected mental-health conditions can cause or worsen acid reflux as a side effect. Under 38 CFR 3.310, a secondary claim requires a current GERD diagnosis and a medical nexus opinion stating that the service-connected condition (or its treatment) caused or aggravated the GERD. The Board's published decisions show GERD claimed secondary to several mental-health conditions: psychotic disorders (n = 98, approx. 45% granted), generalized anxiety disorder (n = 55, approx. 39% granted), obsessive-compulsive disorder (n = 37, approx. 68% granted), major depressive disorder (n = 34, approx. 59% granted), and unspecified depressive disorder (n = 37, approx. 44% granted) (published BVA decisions, secondary-claim dataset). See the PTSD claims guide and nexus letters.

Secondary to obstructive sleep apnea

Sleep apnea is the standout secondary pathway for GERD in the published data. The mechanics are well documented: the pressure changes and arousals of obstructive sleep apnea can promote nighttime acid reflux. In the Board's published decisions, GERD claimed secondary to sleep apnea was granted at the highest rate of any GERD secondary pathway: approx. 81% granted (n = 73, published BVA decisions, secondary-claim dataset). A nexus opinion linking the service-connected sleep apnea to the GERD is the key evidence under 38 CFR 3.310.

Secondary to other service-connected conditions

The published data also surface GERD claimed secondary to service-connected arthritis (n = 44, approx. 69% granted) and to a service-connected peptic ulcer condition (n = 38, approx. 34% granted) (published BVA decisions, secondary-claim dataset). As with every secondary path, the deciding document is a medical opinion that explains the biological link and connects the service-connected primary condition to the GERD. See secondary conditions.

Common Secondary Conditions

Secondary conditions run in two directions: conditions that can cause GERD, and conditions that GERD can in turn cause. The Board's published decisions catalogue both directions, and the grant rates differ sharply by pathway.

Conditions that can cause GERD (GERD as the secondary)

When GERD is claimed as secondary to a service-connected primary condition, each bar is the published BVA grant rate, with the number of decisions below it:

(All figures are grant rates from published BVA decisions, secondary-claim dataset. The mental-health pathways generally reflect medication side effects rather than the mental condition itself.)

Conditions GERD can cause (GERD as the primary)

GERD is itself a recognized cause of downstream secondary claims. Each bar is the published BVA grant rate for a condition claimed secondary to GERD:

Asthma is also claimed secondary to GERD, but on a very small sample (n = 10), so it is not charted here. All figures are from published BVA decisions, secondary-claim dataset.

Pyramiding and Rating Separately

The VA's pyramiding rules prevent paying twice for the same symptoms. The digestive schedule has a specific anti-combining instruction at 38 CFR 4.114. It directs that ratings under a listed group of digestive codes (diagnostic codes 7301 through 7329 inclusive, 7331, 7342, 7345 through 7350 inclusive, 7352, and 7355 through 7357 inclusive) are not combined with each other. Instead, when more than one of those ratings would be warranted, the VA assigns a single evaluation under the code that reflects the predominant disability picture, and elevates it one step if the overall severity warrants it.

Where GERD produces a complication outside the digestive system, Note 2 to DC 7206 directs that the non-gastrointestinal complication be rated under the appropriate body system rather than folded into the GERD rating.

Evidence That Wins These Claims

The Board's published decisions show a clear pattern in which evidence types most often accompany a granted GERD claim. The figures below are grant rates when each evidence type was cited in the decision (published BVA decisions, evidence-type dataset).

• A private nexus letter: approx. 63% granted when cited (n = 2,178). This was the highest-yield evidence type for GERD, well ahead of service treatment records alone at approx. 36% (n = 8,457).
• Medical literature: approx. 59% granted when cited (n = 1,082). Often paired with a nexus opinion to explain the biological mechanism.
• A private medical opinion: approx. 48% granted when cited.
• Buddy or lay statements: approx. 43% granted when cited. Useful for continuity of symptoms, though structural findings carry more weight for GERD.
• The VA examination: approx. 41% granted when cited.
• Service treatment records: approx. 36% granted when cited. The baseline against which the nexus-letter lift is measured.

For the rating level (as opposed to service connection), the deciding evidence is the imaging and procedure record: a barium swallow, CT, or EGD documenting the stricture (per Note 1), plus dilatation procedure notes showing how many dilatations occurred per year and whether any used steroids or involved a stent. See the DBQ guide.

Common Mistakes

Diagnostic Tests and the DBQ

The primary Disability Benefits Questionnaire for this condition is VA Form 21-0960G-1, "Esophageal Conditions (Including Gastroesophageal Reflux Disease (GERD), Hiatal Hernia and Other Esophageal Disorders)." The questions on that form track the rating criteria, so the underlying tests below are what give the form, and the rater, something to work with. The evaluation framework is described in M21-1, Part V, Subpart iii, Chapter 6, Digestive Disabilities.

• Esophagogastroduodenoscopy (EGD, or upper endoscopy): direct visualization of esophagitis, erosions, strictures, and Barrett's esophagus. One of the three imaging methods DC 7206 Note 1 accepts.
• Barium swallow (esophagram, or upper GI series): accepted under DC 7206 Note 1 to document stricture and dysphagia.
• Computed tomography (CT) of the chest or abdomen: the third imaging method accepted under DC 7206 Note 1.
• Esophageal dilatation records and procedure notes: the count and method of dilatations per year (and any steroid dilatation or stent placement) drive the difference between the 30 and 50 percent levels.
• Documentation of daily medication use: proton pump inhibitors (such as omeprazole, pantoprazole, or lansoprazole) or H2 blockers. Per M21-1, daily medication used to control symptoms supports the 10 percent level even without a separately documented stricture.
• Weight and nutrition records and aspiration findings: needed to assess the 80 percent criteria (aspiration, undernutrition, substantial weight loss under 38 CFR 4.112(a)) and any PEG-tube placement.
• 24-hour esophageal pH monitoring and esophageal manometry: sometimes used clinically to confirm reflux and esophageal motility, supporting the diagnosis.

Frequently Asked Questions